Skip to main content
. 2016 Jun 10;7(26):40558–40570. doi: 10.18632/oncotarget.9941

Table 1. Clinical characteristics of patients grouped by the CD4/CD8 ratio (cut off 1.0).

Patient characteristics n = 234 CD4:CD8 ratio
< 1 > 1 p
 Age (years) 61 (20–86)
 Gender (%)
  Male 159 (67.95%)
  Female 75 (32.05%)
Binet stage (%)
  A/B 167 (71.37%) 32 135 0.039
  C 67 (28.63%) 22 45
IGHV (%) n = 197
 Mutated 122 (61.93%) 32 90 0.298
 Unmutated 75 (38.07%) 14 61
CD38 (%) n = 225
 Positive (> 30%) 48 (21.33%) 16 32 0.054
 Negative (< 30%) 177 (78.67%) 35 142
ZAP70 (%) n = 202
 Positive (> 20%) 88 (43.56%) 16 72 0.098
 Negative (< 20%) 114 (56.44%) 33 81
With TP53 mutation or del (17 p) 23 (13.69%) 8 15 0.105
Without TP53 mutation or del (17 p) 145 (86.31%) 28 117